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The structure of the NAD-dependent oxidoreductase UDP-galactose-40-
epimerase from Trypanosoma brucei in complex with cofactor and the substrate
analogue UDP-4-deoxy-4-ﬂuoro--d-galactose has been determined using
diffraction data to 2.7 A ˚ resolution. Despite the high level of sequence and
structure conservation between the trypanosomatid enzyme and those from
humans, yeast and bacteria, the binding of the 4-ﬂuoro--d-galactose moiety is
distinct from previously reported structures. Of particular note is the
observation that when bound to the T. brucei enzyme, the galactose moiety of
this ﬂuoro-derivative is rotated approximately 180  with respect to the
orientation of the hexose component of UDP-glucose when in complex with
the human enzyme. The architecture of the catalytic centre is designed to
effectively bind different orientations of the hexose, a ﬁnding that is consistent
with a mechanism that requires the sugar to maintain a degree of ﬂexibility
within the active site.
1. Introduction
The tsetse-transmitted protozoan parasite Trypanosoma brucei
causes African sleeping sickness in humans and nagana, a disease of
cattle, in sub-Saharan Africa. The disease-causing bloodstream form
ofT. brucei isrich in galactose-containing glycoproteins, including the
protective variant surface glycoproteins (VSGs) that, depending on
the variant, contain galactose (Gal) in glycosylphosphatidylinositol
(GPI) anchor side chains and/or N-linked oligosaccharides (Mehlert
et al., 1998). In addition, the parasite’s transferrin receptor, which is
critical for the acquisition of iron from the host, and various invariant
surface glycoproteins also contain Gal in the form of poly N-acetyl-
lactosamine, i.e. sugar chains containing Gal1-4GlcNAc repeats
(Nolan et al., 1999). Recently, ricin lectin afﬁnity chromatography was
used to isolate glycoproteins bearing terminal non-reducing Gal
residues and these were found to contain a variety of Gal-containing
N-linked oligosaccharides, including a family of novel giant structures
that contain on average 54 N-acetyllactosamine repeats. These ricin-
binding glycoproteins are localized in the ﬂagellar pocket and
throughout the endosomal/lysosomal system of the parasite (Atrih et
al., 2005). The insect-dwelling procyclic form of the parasite also
expresses Gal-containing glycoconjugates, notably the surface
procyclin glycoproteins (Treumann et al., 1997) and free GPI struc-
tures (Vassella et al., 2003; Lillico et al., 2003; Nagamune et al., 2004).
Importantly, neither life-cycle stage can transport Gal across the
plasma membrane (Tetaud et al., 1997) and for galactose metabolism
both are dependent on the NADH-dependent oxidoreductase UDP-
glucose-40-epimerase (EC 5.1.3.2; GalE) encoded by the TbGalE
gene that interconverts UDP-Glc and UDP-Gal (Fig. 1; Roper et al.,
2002, 2005). The same appears to be true of the related parasite
T. cruzi, the causal agent of Chagas’ disease in South and Central
America (MacRae et al., 2006). The African trypanosome requires
UDP-glucose-40-epimerase activity for growth and survival in vitro,
providing genetic validation for this enzyme as a potential drug target
against African trypanosomiasis (Roper et al., 2002).
GalE is a short-chain dehydrogenase/reductase (SDR) (Holden et
al., 2003). Despite displaying an enormous spread of substrate
# 2006 International Union of Crystallography
All rights reservedspeciﬁcities that regulate diverse biological processes, SDRs possess
conserved motifs that are important for aspects of the enzyme
structure, the recognition, binding and orientation of cofactor
(NADH or NADPH) and substrates together with catalysis
(Oppermann et al., 2003; Filling et al., 2002; Shi & Lin, 2004). Three
amino acids are particularly important with respect to catalysis and
two occur in a Tyr-XXX-Lys motif (Holm et al., 1994). The tyrosine is
the catalytic base in the enzyme mechanism and the lysine contri-
butes to binding the cofactor nicotinamide ribose (Gourley et al.,
2001). In addition, a serine or threonine is often associated with the
catalytic tyrosine or with the substrate. In TbGalE the relevant
residues are Ser142, Tyr173 and Lys177.
A mechanism for the TbGalE-catalyzed conversion of an equa-
torial hydroxyl substituent at C4 of glucose to an axial position in
galactose can be described in distinct stages (Shaw et al., 2003). UDP-
Glc ﬁrst binds to the binary complex TbGalE–NAD
+. The nicotin-
amide abstracts a hydride from the glucose C4 as Tyr173 acquires a
proton from the O40 hydroxyl to produce a 4-keto intermediate. For
inversion to occur, hydride transfer from the reduced cofactor must
be to the opposite side of the hexose, a feat only possible after a
rotation of the 4-keto intermediate within the active site. NADH then
transfers the hydride back to C4 with concomitant reprotonation of
the O4 hydroxyl group by Tyr173 to produce UDP-Gal. Ser142 OG
accepts a hydrogen bond from the main-chain amide of Ala144 and
acts as a hydrogen-bond donor to the O40 hydroxyl of substrate. This
is an important contribution to enzyme reactivity since it ensures that
the O40 group on the substrate is committed to be a hydrogen-bond
donor with the phenolic Tyr173 OH and facilitates the H-atom
transfers from and to O40 that occur.
A complete understanding of the speciﬁcity and reactivity of
TbGalE is sought to support the search for new enzyme inhibitors of
TbGalE. Here, we describe the structure of this essential enzyme in
ternary complex with NAD
+ and the substrate analogue UDP-
4-deoxy-4-ﬂuoro--d-galactose (UDP-FGal; Fig. 1b). The ﬂuorine
substitutes for the 40-hydroxyl group from which a proton is
abstracted in the ﬁrst step of the proposed mechanism. A detailed
analysis of the active site and comparisons with the human enzyme
(HsGalE) highlights differences between substrate/product binding
and provides insight into the mechanism of the enzyme together with
clues for inhibitor design.
2. Materials and methods
2.1. Sample preparation
TbGalE, previously cloned into pET15b (Novagen), was heat-
shock transformed in to Escherichia coli strain BL21(DE3)pLysS
(Shaw et al., 2003). Cells were grown in Luria Broth supplemented
with ampicillin (100 mgl
 1) and chloramphenicol (100 mgl
 1). At
mid-log phase, the culture was cooled to 294 K, gene expression was
induced with 0.4 mM isopropyl--d-thiogalactopyranoside and cell
growth was continued overnight. Cells were harvested by centrifu-
gation (2500g) at 277 K, resuspended in binding buffer (25 mM Tris–
HCl, 50 mM NaCl pH 7.5) and lysed using a OneShot cell disrupter
(Constant Systems). Insoluble debris was separated by centrifugation
(40 000g) at 277 K for 20 min and the supernatant was ﬁltered
through a 0.45 mm syringe ﬁlter and then applied onto an Ni
2+-resin
column (GE Healthcare, 5 ml) pre-equilibrated with binding buffer
using an A ¨ KTA Explorer (GE Healthcare). The resin was washed
with binding buffer and protein and then eluted with an increasing
imidazole gradient. Fractions were analyzed by SDS–PAGE and
those containing TbGalE were pooled and dialysed overnight in
binding buffer. The resulting mixture was ﬁltered (0.45 mm) and
applied onto a ResourceQ anion-exchange column (GE Healthcare,
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Figure 1
(a) The epimerization catalyzed by TbGalE, interconverting UDP-Glc and UDP-
Gal. The blue arrow indicates the P
—O anomeric bond about which rotation
occurs during catalysis. (b) The chemical structure of UDP-FGal.
Table 1
Crystallographic statistics.
Values in parentheses are for the highest resolution bin (approximate width 0.07 A ˚ ).
Space group P212121
Unit-cell parameters (A ˚ ) a = 101.72, b = 111.70, c = 160.87
Resolution range (A ˚ ) 92.0–2.7
No. of observed/unique reﬂections 222257/49501
Wilson B factor (A ˚ 2) 64.7
Mosaic spread ( )0 . 9
Completeness (%) 96.8 (78.9)
Multiplicity 4.5 (3.3)
Rmerge (%) 9.0 (47.1)
hI/(I)i 15.2 (2.4)
R factor 19.9 (33.4)
Rfree (%) 28.1 (39.8)
R.m.s.d. from ideal values, bond lengths (A ˚ ) 0.012
R.m.s.d. from ideal values, bond angles ( ) 1.464
Average B values (A ˚ 2)
Overall 48.6
Main chain 48.3
Side chain 48.9
Waters 44.8
NAD
+ 39.4
UDP-FGal 43.4
Ramachandran plot analysis (%)
Residues in most favourable regions 86.3
Residues in allowed regions 13.4
Residues in disallowed regions 0.3
Cruickshank’s DPI† (A ˚ ) based on Rfree 0.4
† Diffraction-component precision index (Cruickshank, 1999).6 ml). TbGalE did not bind to the column and was thus separated
from contaminants that did. Fractions containing TbGalE were
pooled, dialyzed overnight in 25 mM Tris–HCl, 1 mM dithiothreitol
pH 7.5 at 277 K and then concentrated to approximately 20 mg ml
 1
for crystallization. Previous work identiﬁed that crystals could be
obtained without proteolytic removal of the histidine tag. The
enzyme was judged to be greater than 95% pure as assessed by SDS–
PAGE. The synthesis of UDP-FGal followed published methods
(Burton et al., 1997).
2.2. Crystallization and data collection
TbGalE was incubated with 2 mM -NAD
+ (Sigma–Aldrich) and
2m M UDP-FGal at room temperature for 1 h and then used to
assemble hanging drops consisting of 1 ml protein–ligand mixture and
1 ml reservoir solution (8% PEG 8000, 200 mM KCl, 100 mM
Na2B4O7, 10% glycerol pH 8.5). Orthorhombic crystals grew over a
period of 2 d and one (0.3   0.1   0.05 mm) was cryoprotected in
15% 2-methyl-2,4-pentanediol and then ﬂash-cooled in a stream of
nitrogen at 103 K for data collection. Adata set of 238 images, each of
0.5  oscillation, was collected on a Rigaku R-AXIS IV
++ image-plate
detector coupled to a MicroMax-007HF rotating-anode X-ray
generator (Cu K, = 1.5418 A ˚ ) operating at 40 kVand 20 mA. Data
extending to 2.7 A ˚ resolution were processed and scaled with
DENZO and SCALEPACK, respectively (Otwinowski & Minor,
1997). Statistics are presented in Table 1. Although the outer shell of
data (2.8–2.7 A ˚ resolution) is less than 80% complete and weak, with
an Rmerge of nearly 50%, we were content to include these diffraction
terms, given that the hI/(I)i is 2.4, and to trust the beneﬁts of
maximum-likelihood weighting (Murshudov et al., 1997). The
approach appears to have been successful given that the statistics are
acceptable.
2.3. Structure determination and model refinement
The crystal is isomorphous with that previously studied (PDB code
1gy8; Shaw et al., 2003) and analysis was initiated by rigid-body
reﬁnement (REFMAC5; Collaborative Computational Project
Number 4, 1994; Murshudov et al., 1997) using as a starting model the
protein atoms of the four subunits that constitute the asymmetric
unit. Rounds of restrained reﬁnement interspersed with model
building, inspection of electron-density and difference electron-
density maps, ligand and water placement using Coot (Emsley &
Cowtan, 2004) completed the analysis. Non-crystallographic
restraints between the subunits were employed in the early stages of
reﬁnement and were released once waters and ligands were being
identiﬁed. The resulting model is composed of four subunits forming
two physiological dimers (subunits AB and CD). Subunit A
comprises residues  1–150, 157–237 and 249–381, subunit B residues
 1–150, 158–235 and 249–381, subunit C residues  1–152, 158–237
and 248–381 and subunit D residues  1–150, 157–235 and 249–381.
The  1 refers to a serine residue which precedes the initiating
methionine and is an artifact of the expression plasmid that generates
an N-terminal extension. There are several missing residues which
belong to ﬂexible surface loops. Each active site is occupied by well
ordered NAD
+ and UDP-FGal and an example of the electron
density for the latter is presented in Fig. 2. The geometry of the
TbGalE model was acceptable, with 1232 residues in the most
favorable (86.3%) or allowed (13.4%) regions of the Ramachandran
plot (Table 1) as assessed with PROCHECK (Laskowski et al., 1993).
3. Results and discussion
3.1. Overall structure
The structure of TbGalE in this orthorhombic crystal form has
been published (Shaw et al., 2003) and so only a brief overall
description is given here. Each subunit comprises two domains: an
N-terminal nucleotide-binding motif and a smaller C-terminal
substrate-binding domain. The N-terminal domain (residues 1–203
and 271–306) contains a Rossmann fold and comprises a seven-
stranded parallel and twisted -sheet ﬂanked on each side by three
-helices. The C-terminal domain (residues 204–270 and 307–381)
forms a two-stranded parallel -sheet and an -helix bundle. The
N-terminal domain binds the cofactor and the C-terminal domain
binds the UDP-sugar substrate and the catalytic centre is located in a
cleft at the domain–domain interface (Fig. 3). Least-squares super-
position of the C
 atoms of all four subunits on each other indicates
close similarity, with r.m.s.d. values in the range 0.4–0.6 A ˚ . Only
minor differences occur in some surface loops (data not shown). The
cofactor and UDP-FGal overlay well with the corresponding ligands
in the other subunits, with side chains and water-molecule positions
together with inferred interactions being virtually identical between
all four subunits. For this reason it is only necessary to provide details
of a single subunit and that of subunit A has been chosen arbitrarily.
The structure of the ternary complex TbGalE–NAD
+–UDP-FGal
is similar to that of the TbGalE–NAD
+–UDP complex published
previously (Shaw et al., 2003). Superposition of the two structures
gives an r.m.s.d. of 0.4 A ˚ for 1461 C
 positions. The close similarity
even extends to the orientation of side chains in and around the
active site. Superposition of subunit A of TbGalE onto a subunit of
the human enzyme (HsGalE; PDB code 1ek6) gives an r.m.s.d. of
1.2 A ˚ for 314 C
 atoms. An overlay with 307 C
 atoms of the E. coli
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Figure 2
(a) The omit Fo   Fc difference density observed for UDP-FGal binding in the
subunit A active site of TbGalE. The map, depicted as a purple mesh, is contoured
at 2. The ligand is shown as a stick model with atomic positions coloured
according to type: C, grey; N, blue; O, red; P, purple; F, green. This is the ligand
orientation that will be used in all ﬁgures. Figs. 2–5 were prepared with PyMOL
(DeLano, 2002).enzyme (EcGalE; PDB code 1udb) produced an r.m.s.d. of 1.3 A ˚ .T h e
core of the GalE subunit is highly conserved in all three structures,
with differences conﬁned to areas distant from the active site, namely
surface loops and 2o fTbGalE, which adopts a slightly different
orientation compared with HsGalE and EcGalE (not shown)
(Thoden et al., 1996).
3.2. Active site: cofactor and UDP-FGal binding
The cofactor-binding site, as in all SDR family members, is located
at the C-terminal ends of the seven-stranded -sheet. NAD
+ binds
with the adenine in an anti conformation and the nicotinamide syn
with respect to their associated ribose groups. The interactions
between the cofactor and protein are conserved in the TbGalE–
NAD
+–UDP-FGal and TbGalE–NAD
+–UDP complexes. There are
14 hydrogen bonds formed between the cofactor and the protein and
a further ﬁve between cofactor and water molecules in the active site.
Several water molecules also mediate interactions with the protein
(not shown). The majority of residues which hydrogen bond with
NAD
+ (Tyr11, Ile12, Asp32, Asp75, Met98, Asn117, Tyr173 and
Lys177) are conserved between species (Shaw et al., 2003). Hydro-
phobic interactions, several of which involve highly conserved resi-
dues (Gly7, Ser140 and Tyr200), have also been noted (Shaw et al.,
2003).
Key residues in the active site of TbGalE that interact with UDP-
FGal together with selected hydrogen-bonding interactions are
depicted in Fig. 4. The published structure of TbGalE contained a
fragment of the substrate, UDP, in the active site (Shaw et al., 2003)
and, in a similar fashion to the observations made above regarding
cofactor binding, we note a consistency in the association of common
structural components of UDP and UDP-FGal in the two complexes.
Uracil binds in a hydrophobic pocket, sandwiched between Leu222
and Phe255, forming hydrogen-bonding interactions with the main-
chain atoms of Pro253 and Phe255; a pair of residues located on 8.
O4 interacts with a water molecule and potentially forms a C—H   O
hydrogen bond with Pro253. The ribose hydroxyl groups form
hydrogen bonds with the side chains of Cys266 (not shown) and
Asp338. The pyrophosphate moiety interacts with His221 (another
potential C—H   O hydrogen bond), Leu222, Arg268, Arg335 and
nearby water molecules. Although weak (Duax et al., 2003; Leonard
et al., 1995 and references cited therein), these C—H   O hydrogen-
bond interactions serve to assist the association of protein with ligand
because they can alleviate the destabilizing interactions that would
arise owing to the presence of an unsatisﬁed
hydrogen-bond acceptor. C—H   O associations
are commonly observed in high-resolution SDR
structures, in particular contributing to cofactor
placement (Duax et al., 2003).
The new complex now allows us to describe
how a galactose derivative interacts with
TbGalE. The nicotinamide creates the ﬂoor of
the hexose-binding site and is in close proximity
(approximately 3.0 A ˚ ) to the galactose and so is
positioned to participate in hydride transfers. All
functional groups on the galactose participate in
at least one hydrogen bond with surrounding
residues or waters (Fig. 4). The hydroxyl
O20 forms a hydrogen bond with Asn202 ND2,
while O30 interacts with two main-chain
carbonyl groups provided by Tyr200 and
Phe201 and Ser142 OG. O60 interacts with the
carbonyl of Leu102, His221 NE2 and a well
ordered water molecule that in turn associates
with O50, - and -phosphate O atoms. The
ﬂuorine, F4, is 2.7 A ˚ distant from Ser142 OG and
2.8 A ˚ from Tyr173 OH. The location of F4 is
equivalent to the hydroxyl group position if a
substrate (e.g. UDP-Gal; Fig. 1b) were bound
and, as discussed, Tyr173 is the catalytic base that
protein structure communications
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Figure 4
A stereo representation of ligand binding in the active site showing selected residues. Atomic positions are
coloured according to type. C-atom positions of UDP-FGal, NAD
+ and TbGalE are magenta, grey and
wheat, respectively; all O atoms are red, all N atoms blue and P atoms orange; F is green. Two water
molecules are shown as red spheres. Selected potential hydrogen bonds are depicted as yellow dashed lines
and C—H   O interactions as black dashed lines.
Figure 3
Ribbon diagram to show the subunit fold and secondary structure of TbGalE.
-Helices are coloured red and -strands cyan; UDP-FGal and the cofactor are
depicted as sticks and coloured magenta and green, respectively.extracts the 40-hydroxyl hydrogen to produce the ketose inter-
mediate.
In the HsGalE–NAD
+–UDP-Glc complex (PDB code 1ek6;
Thoden et al., 2000), each functional group associated with the hexose
also participates in hydrogen-bonding interactions with the protein.
In the TbGalE–NAD
+–UDP-FGal structure there are seven residues
which bind the galactose group. These are Leu102, Ser142, Tyr173,
Tyr200, Phe201, Asn202 and His221. Five of these are strictly
conserved in HsGalE (Ser132, Tyr157, Tyr185, Phe186 and Asn187).
Leu102 corresponds to Lys92, but since the interaction with the
ligand involves a main-chain group the identity of the amino acid is
less important. His221 in TbGalE is altered to Asn207 in HsGalE, a
conservative substitution since both residue types present an N—H
hydrogen-bond donor group directed towards the hexose-binding
site. This position is also occupied by an asparagine in EcGalE
(Asn199) and in the yeast enzyme (Asn214). However, although
conserved residues are involved in binding the glucose moiety, the
hexose has rotated/ﬂipped through approximately 180  (Fig. 5), with
the O60 hydroxyl groups changing position by 7.5 A ˚ as a consequence
of the different orientations. This alteration to the glucose group
results in different hydrogen-bonding details to those shown in Fig. 4
for the galactose. In HsGalE–NAD
+–UDP-Glc, the O20 and O60
groups of the glucose interact with Asn207 and Asn187, respectively.
Asn187 also forms a hydrogen bond to the -phosphate of the
pyrophosphate moiety. O30 interacts with Tyr157 OH and the
carbonyl group of Lys92, whilst O40 interacts with Ser132 OG and
Tyr157 OH. Since the relevant side-chain functional groups are
conserved in TbGalE, the same interactions are predicted to occur
when UDP-Glc is bound to the parasite enzyme.
The structure of UDP-FGal bound to TbGalE also shows the
galactose in a different orientation compared with the same ligand
when in complex with EcGalE (Fig. 5; Thoden et al., 1997). In the
bacterial enzyme complex the galactose adopts a conformation
intermediate between that of the T. brucei and human enzyme
structures (Fig. 5). These three complexes clearly indicate that the
GalE active site has enough space to allow conformational freedom
of the hexose rings with respect to UDP and the correct placement of
functional groups to accommodate or stabilize different orientations
of the sugars. The design of novel inhibitors targeting TbGalE will
need to take into consideration the variety of hydrogen-bonding
partners that create this open hydrophilic hexose-binding site.
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